BioSpace News Archive

Press Releases

BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study

October 27, 2025
·
9 min read
Press Releases

Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis

October 27, 2025
·
5 min read
Press Releases

Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock

October 27, 2025
·
5 min read
Press Releases

Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs

October 27, 2025
·
4 min read
Press Releases

Lilly’s Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

October 27, 2025
·
12 min read
Press Releases

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

October 27, 2025
·
13 min read
Press Releases

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

October 27, 2025
·
6 min read
Press Releases

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner

October 27, 2025
·
7 min read
Press Releases

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

October 27, 2025
·
6 min read
Press Releases

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

October 27, 2025
·
3 min read